Bryan Richard Hinton - Dec 27, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Technology Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Dec 27, 2021
Transactions value $
-$7,478
Form type
4
Date filed
12/29/2021, 04:19 PM
Previous filing
Dec 7, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $2.81K +260 +2.77% $10.80 9.64K Dec 27, 2021 Direct
transaction HCAT Common Stock Sale -$10.3K -260 -2.7% $39.56 9.38K Dec 27, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -260 -10% $0.00 2.34K Dec 27, 2021 Common Stock 260 $10.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
F2 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.